在IBD中选择使用补充和替代医学 (CAM) 剂
Monica Dzwonkowski1, Janak Bahirwani2, Samantha Rollins1
1Department of Gastroenterology, St. Luke's University Health Network, Bethlehem, PA, USA.
Current gastroenterology reports
|January 17, 2025
概括
本综述探讨了炎症性肠病 (IBD) 的草药疗法,包括克罗恩病和性结肠炎. 虽然注意到有前途的抗炎作用,但由于生物可用性和标准化等局限性,需要进一步研究.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 综合医学是一个整体的医学.
背景情况:
- 炎症性肠病 (IBD) 对患者和医疗保健系统造成了巨大的负担.
- 很大一部分IBD患者探索补充和替代医学 (CAM) 来治疗症状.
- 基于证据的对CAM疗法的理解对于全面的IBD患者护理至关重要.
研究的目的:
- 审查当前关于治疗克罗恩病和性结肠炎的草药疗法的证据.
- 评估在IBD中使用特定草药的益处,潜在危害和考虑因素.
- 为临床医生提供关于为IBD患者提供整体和基于证据的护理的信息,使用非传统治疗方法.
主要方法:
- 对IBD的草药疗法的文献进行系统审查.
- 对研究特定草药的分析,如大麻素,Tripterygium wilfordii,Boswellia serrata和黄素.
- 评估报告的抗炎作用,患者的结果,不良反应和限制.
主要成果:
- 一些草药,包括大麻素,Boswellia serrata和黄素,在IBD患者中表现出抗炎性质和积极的结果.
- 观察到潜在的益处,但大规模的研究通常缺乏大多数研究的草药.
- 经常报告的局限性包括生物可用性差,缺乏配方标准化以及潜在的不良反应.
结论:
- 草药疗法显示出作为IBD辅助治疗的潜力,提供抗炎益处.
- 需要进一步进行严格的临床试验,以确定这些补救措施的有效性,安全性和最佳使用.
- 临床医生应该了解与IBD草药治疗相关的当前数据,益处和风险.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
01:29Inflammatory Bowel Disease IV: Pharmacological Management
109
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
109
01:29Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
314
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
314